idarubicin
UkraineDrugs containing this active substance
-
The drug is used for the treatment of acute myeloid leukemia in adults (for induction of remission or in cases of relapse), as well as a second-line treatment for relapsed acute lymphoblastic leukemia in adults and children. In children, it is also used for the induction of remission in acute myeloid leukemia in combination with cytarabine.
Form: powder for solution for infusion
Active substance Dosage idarubicin 5 mg ATC: L01DB06
Manufacturer: Latina Pharma S.p.A.